During the past decade, Ultramed conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 10 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 10 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ultramed" #1 sponsor was "Arena Pharmaceuticals" with 2 trials, followed by "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ultramed" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator and "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Ultramed" are "Rheumatoid Arthritis" (5 trials), "Ulcerative Colitis" (4 trials), "Arthritis, Psoriatic" (2 trials), "Crohn's Disease" (2 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Ultramed" in a lesser frequency.

Most popular intervention types in "Ultramed" are "Drug" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Etrasimod" (4 trials), "GDC-0853" (2 trials), "Guselkumab" (2 trials) and "Mirikizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ultramed" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Ultramed". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Ultramed, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ultramed, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".